OR WAIT null SECS
Edwards will oversee company's financial, logistical and human-resources operations.
Contract pharmaceutical developer and manufacturer Metrics Inc. has appointed Wes Edwards, MBA, CPA, as its chief financial officer. Edwards brings to Metrics 15 years of corporate and military experience in finance, accounting, supply chain management and pricing. He will oversee the company’s financial, logistica, and human-resources operations.
Last year, the privately held Metrics was acquired by Mayne Pharma Group Limited, a corporation publicly traded on the Australian Securities Exchange (ASX). Going public means Metrics now interacts with newfound stakeholders – such as regulators and investors – who have clear expectations when it comes to financial disclosure, said Phil Hodges, president of Metrics Inc.
Metrics Inc. is a full-service global pharmaceutical development and manufacturing organization serving clients worldwide. Their areas of expertise include quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical trial material (CTM) manufacturing for Phase I, II and III trials; and analytical method development and validation services leading to commercial scale manufacturing.
Source: Metrics Inc.